New challenges and opportunities in adult congenital heart disease

Douglas Moodie

doi:10.1038/ncpcardio0275 | Full Text | PDF (48K)

The why, what, how and when of biological pacemakers

Ira S Cohen, Peter R Brink, Richard B Robinson and Michael R Rosen

doi:10.1038/ncpcardio0276 | Full Text | PDF (73K)

Preoperative CT scanning in chronic thromboembolic pulmonary hypertension

doi:10.1038/ncpcardio0252 | Full Text | PDF (58K)

Sildenafil for patients with pulmonary hypertension secondary to congestive heart failure

doi:10.1038/ncpcardio0253 | Full Text | PDF (67K)

Left-ventricular properties in diastolic heart failure

doi:10.1038/ncpcardio0255 | Full Text | PDF (58K)

Coronary circulatory dysfunction and insulin resistance

doi:10.1038/ncpcardio0254 | Full Text | PDF (60K)

Cardiovascular safety of NSAIDs: case–control analysis

doi:10.1038/ncpcardio0256 | Full Text | PDF (67K)

Low circulating endothelial progenitor cell counts predict cardiovascular events

doi:10.1038/ncpcardio0257 | Full Text | PDF (60K)

Coronary calcium scores independently predict coronary artery disease events

doi:10.1038/ncpcardio0258 | Full Text | PDF (67K)

Statin and antioxidant treatment in asymptomatic adults with high coronary calcium scores

doi:10.1038/ncpcardio0259 | Full Text | PDF (59K)

New nomogram for evaluation of QT interval

doi:10.1038/ncpcardio0260 | Full Text | PDF (66K)

New left-ventricular assist device shows promise in first clinical study

doi:10.1038/ncpcardio0261 | Full Text | PDF (56K)

Subxiphoid pericardiostomy in patients with pericardial effusion

doi:10.1038/ncpcardio0262 | Full Text | PDF (67K)

Calcium-channel-blocker response in idiopathic pulmonary arterial hypertension

doi:10.1038/ncpcardio0263 | Full Text | PDF (59K)

Does participation in a trial affect clinical outcome?

doi:10.1038/ncponc0268 | Full Text | PDF (59K)

Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?

Cheuk-Kit Wong and Harvey D White

doi:10.1038/ncpcardio0277 | Full Text | PDF (75K)

Can angiographically silent coronary atherosclerosis predict mortality after cardiac transplantation?

Ik-Kyung Jang

doi:10.1038/ncpcardio0269 | Full Text | PDF (72K)

Can early diastolic velocity of the mitral annulus predict survival in patients with impaired left-ventricular function?

Christian Bruch

doi:10.1038/ncpcardio0273 | Full Text | PDF (74K)

Primary angioplasty versus prehospital thrombolysis: how do the treatment costs compare?

Menko-Jan de Boer

doi:10.1038/ncpcardio0267 | Full Text | PDF (72K)

Does intravascular ultrasound accelerate atherosclerosis progression in native nontransplant coronary arteries?

Eric H Yang and Amir Lerman

doi:10.1038/ncpcardio0278 | Full Text | PDF (73K)

Does raising high-density lipoprotein cholesterol level benefit patients with coronary artery disease?

M John Chapman

doi:10.1038/ncpcardio0246 | Full Text | PDF (75K)

Treatment of unprotected left main coronary artery disease with drug-eluting stents: is it time for a randomized trial?

Alaide Chieffo and Antonio Colombo

doi:10.1038/ncpcardio0272 | Full Text | PDF (156K)

The role of shear stress in the generation of rupture-prone vulnerable plaques

CJ Slager, JJ Wentzel, FJH Gijsen, JCH Schuurbiers, AC van der Wal, AFW van der Steen and PW Serruys

doi:10.1038/ncpcardio0274 | Full Text | PDF (196K)

Mechanisms of Disease: current understanding and future challenges in Brugada syndrome

Wataru Shimizu, Takeshi Aiba and Shiro Kamakura

doi:10.1038/ncpcardio0268 | Full Text | PDF (333K)

Drug Insight: an overview of current anticoagulation therapy after heart valve replacement

Detlef Hering, Cornelia Piper and Dieter Horstkotte

doi:10.1038/ncpcardio0271 | Full Text | PDF (160K)